IMVT
Biotechnology · Healthcare
Head of Investor Relations
Head of Investor Relations
Immunovant, Inc. (IMVT)Equibles does not estimate personal net worth.
Get an email with a short summary when Immunovant, Inc. publishes a filing, an earnings call transcript or a press release.
Get IMVT alertsStephanie Lee is recorded as Head of Investor Relations at Immunovant, Inc. (IMVT). Stephanie Lee has spoken on 1 earnings call across 1 company, most recently for Immunovant, Inc. on February 6, 2026. Immunovant, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunovant, Inc. includes Eric Venker (CEO), Eric Venker, M.D. (CEO and Board Member), Eric Venker, M.D., Pharm.D. (CEO) and 7 others.
“Good morning, and thanks for joining today's call to review positive Phase 2 results for breakfast whitnip and cutaneous sarcoidosis, and Roy Vance financial results for the third quarter ended December 31, 2025.”
IMVT
Biotechnology · Healthcare
Head of Investor Relations